Rebecca Sadler

2.8k total citations · 1 hit paper
19 papers, 1.8k citations indexed

About

Rebecca Sadler is a scholar working on Molecular Biology, Biological Psychiatry and Neurology. According to data from OpenAlex, Rebecca Sadler has authored 19 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Biological Psychiatry and 5 papers in Neurology. Recurrent topics in Rebecca Sadler's work include Gut microbiota and health (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Tryptophan and brain disorders (5 papers). Rebecca Sadler is often cited by papers focused on Gut microbiota and health (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Tryptophan and brain disorders (5 papers). Rebecca Sadler collaborates with scholars based in United States, Germany and Sweden. Rebecca Sadler's co-authors include George L. Bakris, Arthur Liesz, Stefan Roth, Vikramjeet Singh, Gemma Llovera, Martin Dichgans, J. Brian Copley, Debora Garzetti, Bärbel Stecher and Sue E. Leurgans and has published in prestigious journals such as Journal of Neuroscience, Gastroenterology and Stroke.

In The Last Decade

Rebecca Sadler

18 papers receiving 1.8k citations

Hit Papers

Microbiota Dysbiosis Controls the Neuroinflammatory Respo... 2016 2026 2019 2022 2016 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rebecca Sadler United States 14 765 493 415 390 346 19 1.8k
Roberto Aquilani Italy 28 675 0.9× 428 0.9× 118 0.3× 114 0.3× 81 0.2× 88 2.4k
Federica Boschi Italy 26 595 0.8× 269 0.5× 53 0.1× 93 0.2× 176 0.5× 96 2.2k
Julie A. Lovshin Canada 25 672 0.9× 310 0.6× 243 0.6× 52 0.1× 1.7k 4.9× 58 2.5k
Salim Thabet United States 9 274 0.4× 548 1.1× 68 0.2× 106 0.3× 452 1.3× 12 1.7k
Sergio Neri Italy 25 273 0.4× 163 0.3× 94 0.2× 85 0.2× 267 0.8× 110 2.2k
Aozhou Wu United States 14 134 0.2× 227 0.5× 108 0.3× 130 0.3× 125 0.4× 45 1.0k
Robert DiRaimo United States 6 521 0.7× 219 0.4× 41 0.1× 503 1.3× 94 0.3× 7 1.7k
Masanori Iwase Japan 29 395 0.5× 540 1.1× 197 0.5× 33 0.1× 965 2.8× 110 2.6k
E. Graff Israel 23 223 0.3× 299 0.6× 117 0.3× 23 0.1× 391 1.1× 67 1.7k
Jaimar C. Rincon Venezuela 17 168 0.2× 204 0.4× 157 0.4× 85 0.2× 189 0.5× 43 1.1k

Countries citing papers authored by Rebecca Sadler

Since Specialization
Citations

This map shows the geographic impact of Rebecca Sadler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca Sadler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca Sadler more than expected).

Fields of papers citing papers by Rebecca Sadler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca Sadler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca Sadler. The network helps show where Rebecca Sadler may publish in the future.

Co-authorship network of co-authors of Rebecca Sadler

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca Sadler. A scholar is included among the top collaborators of Rebecca Sadler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca Sadler. Rebecca Sadler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Sadler, Rebecca, et al.. (2025). The differential effect of Interferon-gamma on acute kidney injury and parasitemia in experimental malaria. Scientific Reports. 15(1). 6402–6402.
2.
Aswendt, Markus, Rebecca Sadler, Gemma Llovera, et al.. (2021). The gut microbiota modulates brain network connectivity under physiological conditions and after acute brain ischemia. iScience. 24(10). 103095–103095. 17 indexed citations
3.
Sadler, Rebecca, Steffanie Heindl, Sarantos Kostidis, et al.. (2019). Short-Chain Fatty Acids Improve Poststroke Recovery via Immunological Mechanisms. Journal of Neuroscience. 40(5). 1162–1173. 243 indexed citations
4.
Singh, Vikramjeet, Rebecca Sadler, Steffanie Heindl, et al.. (2018). The gut microbiome primes a cerebroprotective immune response after stroke. Journal of Cerebral Blood Flow & Metabolism. 38(8). 1293–1298. 98 indexed citations
5.
Benakis, Corinne, Rebecca Sadler, Vikramjeet Singh, Stefan Roth, & Arthur Liesz. (2018). Abstract TP259: Tryptophan Metabolism Affects the Intestinal Immune Response After Stroke. Stroke. 49(Suppl_1). 1 indexed citations
6.
Sadler, Rebecca, Vikramjeet Singh, Corinne Benakis, et al.. (2017). Microbiota differences between commercial breeders impacts the post-stroke immune response. Brain Behavior and Immunity. 66. 23–30. 46 indexed citations
7.
Memic, Fatima, Viktoria Knoflach, Khomgrit Morarach, et al.. (2017). Transcription and Signaling Regulators in Developing Neuronal Subtypes of Mouse and Human Enteric Nervous System. Gastroenterology. 154(3). 624–636. 66 indexed citations
8.
Singh, Vikramjeet, Stefan Roth, Gemma Llovera, et al.. (2016). Microbiota Dysbiosis Controls the Neuroinflammatory Response after Stroke. Journal of Neuroscience. 36(28). 7428–7440. 560 indexed citations breakdown →
9.
Memic, Fatima, Viktoria Knoflach, Rebecca Sadler, et al.. (2016). Ascl1 Is Required for the Development of Specific Neuronal Subtypes in the Enteric Nervous System. Journal of Neuroscience. 36(15). 4339–4350. 34 indexed citations
10.
Bohmann, Ferdinand O., Kavi Devraj, Peter Kraft, et al.. (2016). Reliability of infarct volumetry: Its relevance and the improvement by a software-assisted approach. Journal of Cerebral Blood Flow & Metabolism. 37(8). 3015–3026. 13 indexed citations
11.
Lindberg, Jill S., et al.. (2003). Clinical management of dialysis-related carnitine deficiency: three case studies.. PubMed. 17(5). 73–6, 78. 1 indexed citations
12.
Sadler, Rebecca. (2000). Vitamin D Therapy in Patients With Chronic Renal Disease: The Role of the Renal Dietitian. Advances in Renal Replacement Therapy. 7(4). 358–364. 2 indexed citations
13.
Stehman‐Breen, Catherine, et al.. (1999). Racial differences in bone mineral density and bone loss among end-stage renal disease patients. American Journal of Kidney Diseases. 33(5). 941–946. 54 indexed citations
14.
Lindberg, Jill S., Sharon Anderson, Molly Szerlip, et al.. (1999). The healthy start renal clinic: benefits of tracking and early intervention in pre-end stage renal disease patients.. PubMed. 1(4). 202–5. 2 indexed citations
15.
Llach, Francisco, Rebecca Sadler, James A. Delmez, et al.. (1998). Suppression of parathyroid hormone secretion in hemodialysis patients by a novel vitamin D analogue: 19-nor-1,25-dihydroxyvitamin D2. American Journal of Kidney Diseases. 32(4). S48–S54. 75 indexed citations
16.
Bakris, George L., et al.. (1997). Effect of Calcium Channel or β-Blockade on the Progression of Diabetic Nephropathy in African Americans. Hypertension. 29(3). 744–750. 112 indexed citations
17.
Bakris, George L., et al.. (1996). Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy. Kidney International. 50(5). 1641–1650. 299 indexed citations
18.
Bakris, George L., et al.. (1994). ACE inhibitor mediated reductions in renal size and microalbuminuria in normotensive, diabetic subjects. Journal of Diabetes and its Complications. 8(1). 2–6. 54 indexed citations
19.
Bakris, George L., et al.. (1992). Treatment of arterial hypertension in diabetic humans: Importance of therapeutic selection. Kidney International. 41(4). 912–919. 168 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026